Clinical Trial Update: A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update announces a Phase 1/2 open-label study of CRMA-1001 in adults with chronic hepatitis B, evaluating single and multiple ascending dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• CRMA-1001

Snippet

Sponsor: nChroma Bio | Conditions: Chronic Hepaititis B | Phase 1, Phase 2 | Status: RECRUITING